In case of tissue insufficiency, ctDNA acquired through liquid biopsy can be tested7,8
- ctDNA is obtained through minimally invasive methods to study biomarkers in body fluids (eg, blood)9,10
- ctDNA testing can be used to detect genomic alterations that can be linked to targeted therapy options11